80/100BAgilent Technologies stock forecast 2026–2030What is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Analysts' average 12-month price target for Agilent Technologies is 174.29, 1.8% above the current price of 171.26. Their targets range from 150.00 to 195.00.
Of the 17 firms that rated Agilent Technologies in the past 12 months, 15 rate it buy or strong buy, 2 hold and 0 sell or strong sell (each firm at its latest rating): a Strong buy consensus.
Analysts' 1-year price targets range from 150.00 to 195.00, with an average of 174.29.
| Buy | 15 | |
| Hold | 2 | |
| Sell | 0 |
12-month price target
| Highest target | 195.00 |
| Average target | 174.29 |
| Lowest target | 150.00 |
| Current price | 171.26 |
Agilent Technologies price target historyWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Have analysts recently raised or lowered their Agilent Technologies price target and rating?
How analysts rate Agilent Technologies, month by monthWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
15 of 17 firms rate it buy now, against 7 of 11 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
Agilent Technologies analyst upgrades, downgrades and price targets
The latest rating change came on 11 June 2026, when Piper Sandler downgraded Agilent Technologies from Overweight to Neutral. Its price target is 150.00. The most recent new target came from Deutsche Bank on 26 October 2026: 190.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 26 Oct 2026 | Deutsche Bank Justin Bowers | — | 190.00 | — | 175.93 |
| 12 Oct 2026 | Morgan Stanley | — | 180.00 → 190.00 | +5.6% | 171.47 |
| 7 Oct 2026 | Barclays | Reiterated · Overweight | 175.00 → 195.00 | +11.4% | 169.33 |
| 9 Sept 2026 | UBS | — | 180.00 → 165.00 | -8.3% | 146.85 |
| 2 Sept 2026 | Jefferies | — | 130.00 → 155.00 | +19.2% | 151.56 |
| 27 Aug 2026 | Wells Fargo | — | 160.00 → 180.00 | +12.5% | 157.69 |
| 27 Aug 2026 | Barclays Luke Sergott | Reiterated · Overweight | 140.00 → 175.00 | +25.0% | 157.98 |
| 27 Aug 2026 | RBC Capital | Reiterated · Outperform | 180.00 → 185.00 | +2.8% | 158.78 |
| 27 Aug 2026 | RBC Capital | — | 155.00 → 180.00 | +16.1% | 157.92 |
| 27 Aug 2026 | Evercore ISI Vijay Kumar | Reiterated · Outperform | 148.00 → 172.00 | +16.2% | 155.17 |
| 27 Aug 2026 | Bernstein | Reiterated · Outperform | 180.00 | — | 155.17 |
| 27 Aug 2026 | Goldman Sachs Evie Koslosky | Reiterated · Buy | 170.00 → 175.00 | +2.9% | 155.17 |
| 27 Aug 2026 | Stifel Nicolaus Daniel Arias | Reiterated · Buy | 170.00 → 180.00 | +5.9% | 155.17 |
| 6 Jul 2026 | Evercore ISI Vijay Kumar | Reiterated · Outperform | 160.00 → 148.00 | -7.5% | 128.34 |
| 11 Jun 2026 | Piper Sandler David Westenberg | Downgraded · Overweight → Neutral | 150.00 | — | 131.62 |
| 3 Jun 2026 | HSBC Sidharth Sahoo | Reiterated · Buy | 180.00 → 165.00 | -8.3% | 135.04 |
| 28 May 2026 | RBC Capital | Reiterated · Outperform | 153.00 → 155.00 | +1.3% | 133.51 |
| 28 May 2026 | Robert W. Baird | — | 156.00 → 158.00 | +1.3% | 115.83 |
| 28 May 2026 | Wells Fargo Brandon Couillard | Reiterated · Overweight | 165.00 → 160.00 | -3.0% | 115.83 |
| 28 May 2026 | B of A Securities | Upgraded · Neutral → Buy | — | — | — |
| 26 May 2026 | RBC Capital Dan Leonard | — | 153.00 | — | 115.08 |
| 26 May 2026 | Robert W. Baird Catherine Ramsey Schulte | — | 165.00 → 156.00 | -5.5% | 114.96 |
| 14 Apr 2026 | Barclays Luke Sergott | Reiterated · Overweight | 165.00 → 140.00 | -15.2% | 117.52 |
| 9 Mar 2026 | Fermium Research | — | 150.00 | — | 114.21 |
| 20 Jan 2026 | HSBC | — | 180.00 | — | 139.64 |
| 5 Jan 2026 | Evercore ISI | Upgraded · In Line → Outperform | 160.00 | — | 137.95 |
| 15 Dec 2025 | Barclays | Upgraded · Equal Weight → Overweight | — | — | — |
| 9 Dec 2025 | Goldman Sachs | — | 170.00 | — | 142.44 |
| 2 Dec 2025 | Morgan Stanley | — | 270.00 → 180.00 | -33.3% | 148.81 |
| 1 Dec 2025 | Morgan Stanley | — | 270.00 | — | 150.10 |
| 25 Nov 2025 | Stifel Nicolaus Daniel Arias | — | 170.00 | — | 158.23 |
| 25 Nov 2025 | UBS | Reiterated · Buy | 180.00 | — | 153.60 |
| 25 Nov 2025 | Robert W. Baird Catherine Ramsey Schulte | — | 142.00 → 165.00 | +16.2% | 153.60 |
| 25 Nov 2025 | Barclays | Reiterated · Equal Weight | 150.00 → 165.00 | +10.0% | 153.60 |
| 25 Nov 2025 | Wells Fargo | Reiterated · Overweight | 140.00 → 165.00 | +17.9% | 153.60 |
Agilent Technologies EPS and revenue estimatesWhat are estimate revisions? Estimate revisions are the changes analysts make to their EPS and revenue forecasts for the years ahead. They show whether expectations are rising or falling.
Analysts expect Agilent Technologies's EPS to grow 17.5% a year until 2028. Over the last 5 years it grew 14.7% a year, and over the last 3 years 3.0%.
Analysts expect Agilent Technologies's revenue to grow 7.0% a year until 2028. Over the last 5 years it grew 5.4% a year, and over the last 3 years 0.5%.
Revenue
EPS
Does Agilent Technologies beat earnings estimates?What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
On average, analysts' EPS estimate was 3.4% off the result, either way, and their revenue estimate 2.1%, over the last 12 quarters.
- EPS beats
- 77 / 104
- Revenue beats
- 67 / 104
- Average EPS surprise, last 12What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
- +3.3%
- Since
- February 2000
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 26 Aug 2026 | 1.49 | 1.62 | +8.7% | 1.84B | 1.88B | +2.0% |
| Q2 FY2026 | 27 May 2026 | 1.41 | 1.49 | +5.7% | 1.80B | 1.84B | +2.0% |
| Q1 FY2026 | 25 Feb 2026 | 1.37 | 1.36 | -0.7% | 1.81B | 1.80B | -0.5% |
| Q4 FY2025 | 24 Nov 2025 | 1.58 | 1.59 | +0.4% | 1.83B | 1.84B | +0.4% |
| Q3 FY2025 | 27 Aug 2025 | 1.37 | 1.37 | 0.0% | 1.68B | 1.74B | +3.2% |
| Q2 FY2025 | 28 May 2025 | 1.26 | 1.31 | +4.0% | 1.63B | 1.67B | +2.5% |
| Q1 FY2025 | 26 Feb 2025 | 1.28 | 1.31 | +2.3% | 1.67B | 1.68B | +0.7% |
| Q4 FY2024 | 25 Nov 2024 | 1.41 | 1.46 | +3.5% | 1.67B | 1.70B | +1.7% |
| Q3 FY2024 | 21 Aug 2024 | 1.26 | 1.32 | +4.8% | 1.56B | 1.58B | +1.3% |
| Q2 FY2024 | 29 May 2024 | 1.19 | 1.22 | +2.5% | 1.58B | 1.57B | -0.6% |
| Q1 FY2024 | 27 Feb 2024 | 1.22 | 1.29 | +5.7% | 1.59B | 1.66B | +4.4% |
| Q4 FY2023 | 20 Nov 2023 | 1.34 | 1.38 | +3.0% | 1.59B | 1.69B | +6.4% |
Agilent Technologies stock price 2026–2030: scenariosHow are the stock price scenarios calculated? Bear, base and bull prices for the years ahead: the analysts' EPS estimates times the lowest, average and highest P/E of the stock today and at its last five year ends, or of its peers.
If Agilent Technologies's earnings keep growing at the 9.9% a year analysts expect to FY2028, it would earn about 8.96 a share in FY2030. At the P/E it has traded at over the last five years (24.5 to 39.5) that is 219.59 to 353.77 a share, or 286.66 at its average P/E of 32.0. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2026 | 6.20 | 151.92 | 198.31 | 244.74 |
| FY2027 | 6.70 | 164.12 | 214.25 | 264.41 |
| FY2028 | 7.42 | 181.66 | 237.14 | 292.65 |
| FY2029 (extrapolated) | 8.15 | 199.73 | 260.73 | 321.76 |
| FY2030 (extrapolated) | 8.96 | 219.59 | 286.66 | 353.77 |
Each year's EPS is the analysts' consensus to FY2028; the years after grow 9.9% a year (the analysts' growth, at most 15%). Bear, base and bull apply the lowest, average and highest P/E of today and the last five fiscal year ends, leaving out any above 60, the mark of a year of collapsed earnings (24.5, 32.0, 39.5).
Is Agilent Technologies stock undervalued or overvalued?How does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
Agilent Technologies's P/E of 33.6 is near the top of its 5-year range (22.7 to 50.7, median 29.9). Analysts expect faster growth than in recent years, which can explain part of the high P/E. Buyers pay about the usual price for each point of growth: a PEG of 1.9 on expected growth against 2.0 on its median P/E and past five years' growth. At its usual P/E (29.9 × EPS of 5.09), Agilent Technologies's fair value is 152.06; the price, 171.26, is 12.6% above it. Its forward P/E, on the consensus for FY2027, is 25.6.
Fair value is the usual (median) P/E of the last five years times the earnings per share of the last twelve months; the ends of the bar are the same earnings at its lowest and highest P/E of those years (22.7 and 50.7). The price against its P/E range
- Price to earnings ratio (TTM)What is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 33.65
- Five-year median P/EWhat is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 29.87
- Five-year P/E range
- 22.7 – 50.7
- Forward P/E (FY2027)What is the forward P/E ratio? Forward P/E divides a share's price by the earnings per share analysts expect in the coming year, rather than last year's actual earnings.
- 25.56
- PEG ratioWhat is the PEG ratio? The PEG ratio divides the P/E by the yearly earnings growth analysts expect, to show how much you pay for each point of growth.
- 3.38
- To the average targetWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
- +1.8%
Most undervalued US stocksHow does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 35.850 | 71.4258Price 35.85193 | +99.2% | |
| 29.050 | 56.2634Price 29.0596 | +93.7% | |
| 241.000 | 464.49205Price 241.00627 | +92.7% | |
| 123.590 | 237.24178Price 123.59297 | +92.0% | |
| 161.400 | 305.52159Price 161.40396 | +89.3% | |
| 157.460 | 297.58169Price 157.46471 | +89.0% | |
| 217.560 | 405.38304Price 217.56507 | +86.3% |
Furthest below the fair value on each stock's page, updated every day.